Logica Implementation Guide: Covid-19
0.8.0 - CI Build

Logica Implementation Guide: Covid-19 - Local Development build (v0.8.0). See the Directory of published versions

Artifacts Summary

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

Structures: Abstract Profiles

These are profiles on resources or data types that describe patterns used by other profiles, but can't be instantiated directly. I.e. instances can conform to profiles *based* on these abstract profiles, but don't declare conformance to the abstract profiles themselves.

COVID 19 Exposure Core profile A parent, abstract profile to be used for the CDC COVID 19 PUI report form exposure section elements.
Coded Laboratory Observation Base Abstract base class for coded laboratory observations.
Laboratory Observation Base Abstract base class for laboratory observations.
Laboratory Observation Panel Base A panel that contains member observations
Quantitative Laboratory Observation Base Abstract base class for quantitative laboratory observations.

Structures: Resource Profiles

These define constraints on FHIR resources that need to be complied with by conformant implementations

COVID 19 Exposure Questionnaire A list of questions about one's exposure history for COVID 19.
COVID-19 gastrointestinal and hepatic underlying condition An assertion that a specific gastrointestinal or hepatic condition is present as an underlyer to COVID19.
COVID-19 hemoglobinopathy underlying condition An assertion that a specific hemoglobinopathy condition is present as an underlying to COVID19.
COVID-19 ICD 10 Diagnosis A diagnosis or diagnoses asserted about the subject that is due to infection by the SARS coronavirus 2 virus and using codes specific to the ICD 10 code system.
COVID-19 immune underlying condition An assertion that a specifid immune condition is present as an underlying to COVID19.
COVID-19 renal underlying condition An assertion that a specific renal condition is present as an underlyer to COVID19.
COVID-19 respiratory underlying condition An assertion that a specific repsiratory condition is present as an underlyer to COVID19.
COVID-19 SNOMED Diagnosis A diagnosis or diagnoses asserted about the subject that is due to infection by the SARS coronavirus 2 virus and using codes specifically from the SNOMED CT code system.
COVID 19 Symptoms Absent A parent profile for the assertion of the Absence COVID 19 symptoms.
COVID 19 Symptoms Present A parent profile for the assertion of the presence COVID 19 symptoms.
COVID19 uncategorized underlying condition An assertion that an uncategorized medical condition is present as an underlyer to COVID19.
COVID-19 cardiovascular underlying condtition An assertion that a specific cardiovascular condition is present as an underlyer to COVID19.
COVID-19 immunocompromised underlying condition An assertion that a specific immunocompromised condition is present as an underlyer to COVID19.
COVID-19 General Comorbidities Absent An assertion that generalized conditions such as chronic respiratory disease ARE NOT present along with the COVID19 disease.
COVID-19 General Comorbidities Present An assertion that genrealized conditions such as chronic respiratiory disease are also present with the COVID19 disease.
COVID-19 metabolic underlying condition An assertion that a specific metabolic condition is present as an underlyier to COVID19.
COVID-19 neuroligic underlying condition An assertion that a specific neuroligical condition is present as an underlyer to COVID19.
Case-Patient Report Identifying Information The identifying information for a reportable disease or condition.
Gestational Age at Onset of Illness The number of weeks the subject was pregnant when a given illness began.
Human coronavirus 229E+HKU1+OC43+NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection Humancoronavirus229EHKU1OC43NL63RNAPrThrPtNphOrdNonprobeamptar is a test for the Human coronavirus 229EHKU1, OC43, NL63 nucleaic acids in nasopharynx specimens via non-probe, target amplification method
Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection Humancoronavirus229ERNAPrThrPtNphOrdNonprobeamptarLabObs is a test for the Human coronavirus 229E nucleaic acid in nasopharynx specimens via non-probe, target amplification method.
Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection HumancoronavirusHKU1RNAPrThrPtNphOrdNonprobeamptarLabObs is a test for the Human coronavirus HKU1 nucleaic acid in nasopharynx specimens via non-probe, target amplification method.
Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection HumancoronavirusNL63RNAPrThrPtNphOrdNonprobeamptarLabObs is a test for the Human coronavirus NL63 nucleaic acid in nasopharynx specimens via non-probe, target amplification method.
Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection HumancoronavirusOC43RNAPrThrPtNphOrdNonprobeamptarLabObs is a test for the Human coronavirus OC43 nucleaic acid in nasopharynx specimens via non-probe, target amplification method.
Known Exposure Known Exposure is a description of how, when, where, and with whom and individual was exposed to a contagion.
Pregnancy Status An individual's pregnancy state.
SARS-CoV-2 (COVID19) IgG Ab [Presence] in DBS by Immunoassay SARCCoV2AbIgGPrThrPtBldDotOrsdIA is a test for the SARS-CoV-2 (COVID19) IgG antibody via immunoassay on blood filer paper.
SARS-CoV-2 (COVID19) Ab [Units/volume] in Serum or Plasma by Immunoassay SARSCoV2AbACncPtSerPlasQnIA is a quantitative test for the amount of SARS-CoV-2 (COVID19) anitboy in serum or plasma via immnoassay.
SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum, Plasma, or Blood by Rapid imunoassay SARSCoV2AbIgAPrThrPtSerPlasBldOrdIARapid is a test for the presence of the SARS-CoV-2 (COVID19) IgA antibody in serum, plasma, or blood via rapid immunoassay.
SARS-CoV-2 (COVID19) IgA + IgM [Presence] in Serum or Plasma by Immunoassay SARSCoV2AbIgAplusIgMPrThrPtSerPlasordIA is a qualitative test for the SARS-CoV-2 (COVID19) IgA or IgM antibodies via immunoassay in serum or plasma specimens.
SARS-CoV-2 (COVID19) Ab [Presence] in Serum or Plasma by Immunoassay SARSCoV2AbPrThrPtSerPlasOrdIA is a test for the detection of antibodies to SARS-CoV-2 (COVID19) via imunoassay in serum or plasma.
SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay SARSCoV2AgRespQlIArapidLabObs is a test for the SARS-CoV-2 (COVID19) antigen via rapid immunoassay. LOINC code 94558-4.
SARS-CoV-2 (COVID19) E gene [Presence] in Respiratory specimen by NAA with probe detection SARSCoV2EgenePrThrPtRespOrdProbAmpTar is a test for the detection of the SARS-CoV-2 (COVID19) E gene via NAA with probe detection in respiratory specimens
SARS-CoV-2 (COVID19) E gene [Presence] in Serum or Plasma by NAA with probe detection SARSCoV2EgenePrThrPtSerPlasOrdProbAmpTar is a test for the detection of the SARS-CoV-2 (COVID19) E gene via NAA probe detection in serum or plasma specimens.
SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection SARSCoV2NgenePrThrPtNphOrdProbAmpTar is a test for the detection of the SARS-CoV-2 (COVID19) N gene via target amplification in nasopharynx specimens
SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1 SARSCoV2NgenePrThrPtRespOrdProbAmpTarN1 is a test for the detection of the SARS-CoV-2 (COVID19) N gene via nucleic acid amplification using CDC primer-probe set N1 in respiratory specimens.
SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleaic acid amplification using CDC primer-probe set N2 SARSCoV2NgenePrThrPtRespOrdProbAmpTarN2 is a test for the detection of the SARS-CoV-2 (COVID19) N gene via nucleic acid amplification using CDC primer-probe set N2 in respiratroty specimens
SARS-CoV-2 (COVID19) N gene [Presence] in Serum or Plasma by NAA with probe detection SARSCoV2NgenePrThrPtSerPlasOrdProbAmpTar is a test for the detection of the SARS-CoV-2 (COVID19) N gene via NAA probe detection in serum or plasma specimens.
SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1 SARScoronavirus2NgenePrThrPtXXXOrdPrbAmpTarPrimerProbeSetN1 is a test for the SARS-CoV-2 (COVID19) RNA using the CDC defined method of probe amplification target primer probe set N1 and used for non-respiratory specimens. LOINC code 94307-6.
SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2 SARScoronavirus2NgenePrThrPtXXXOrdPrbAmpTarPrimerProbeSetN2 is a test for the SARS-CoV-2 (COVID19) RNA using the CDC defined method of probe amplification target primer probe set N2 and used for non-respiratory specimens. LOINC code 94308-4.
SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1 SARSCoV2NgeneThreshNumPtXXXQnPrbAmpTarPrimerProbeSetN1LabObs is a quantitative test for the SARS-CoV-2 (COVID19) N gene via the probe target amplification, primer probe set N1 method in non-respiratory specimens. LOINC code 94311-8.
SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2 SARSCoV2NgeneThreshNumPtXXXQnPrbAmpTarPrimerProbeSetN2LabObs is a quantitative test for the SARS-CoV-2 (COVID19) N gene via the probe target amplification, primer probe set N2 method in non-respiratory specimens. LOINC code 94312-6.
SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection SARSCoV2ORF1abRespQlNAAprobeLabObs is a laboratory test for the SARS-CoV-2 (COVID19) antibody via target amplification probe detection. LOINC code 94559-2.
SARS-CoV-2 (COVID19) [Presence] in Unspecified specimen by Organism specific culture SARSCoV2PrThrPtXXXOrdOrganismSpecificCulture is a test for the detection of growth of the SARS-CoV-2 (COVID19) organism via organism specific culture.
SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Respiratory specimen by NAA with probe detection SARSCoV2RNACycleThresholdRespQnNAAProbAmpTar is a quantitative test for SARS-CoV-2 (COVID19) RNA via NAA with probe dection cycle threshold # in respiratory specimens.
SARS-CoV-2 (COVID19) RNA [Log#/volume] (viral load) in Unspecified specimen by NAA with probe detection SARSCoV2RNALnCncPtXXXQnProbAmpTar is a quantitative test for the viral load (log number per volume) of SARS-CoV-2 (COVID19) RNA via NAA probe detection in unspecified specimens.
SARS-Cov-2 (COVID19) RNA panel - Unspecified specimen by NAA with probe detection SARSCoV2RNAPnlXXXNAAprobeLabObs is a colection of tests for the SARS-CoV-2 (COVID19) organism. LOINC code 94306-8.
Sars-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with probe detection SARSCoV2RNAPrThrPtNphOrsdProbAmpTar is a test for the detection of SARS-CoV-2 (COVID19) RNA via probe target amplification in nasopharynx specimens.
SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by NAA with probe SARSCoV2RNAPrThrPtSalivaOrdProbAmpTar is a qualitative test for the detection of SARS-CoV-2 (COVID19) RNA via NAA probe detection in saliva (oral fluid).
SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by Seqencing SARSCoV2RNAPrThrPtSalivaOrdSequencing is a qualitative test for the detection of SARS-CoV-2 (COVID19) RNA via RNA sequencing in saliva (oral fluid) specimen.
SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Unspecified specimen by NAA with probe detection SARSCoV2RNAThreshNumPtXXXQnProbAmpTar is a quantitative test for SARS-CoV-2 (COVID19) RNA via NAA with probe detection and a threshold number detection limit in unspecified specimens.
SARS-CoV-2 (COVID19) S gene [Presence] in Serum or Plasma by NAA with probe detection SARSCoV2SgenePrThrPtSerPlasOrdProbAmpTar is test for the detection of the SARS-CoV-2 (COVID19) S gene via target amplification in serum or plasma specimens.
SARS-coV-2 (COVID19) whole genome [Nucleiotide sequence] in Isolate by Sequencing SARSCoV2wholegenomeSeqPtIsolateNomSequencing is a test to sequence the SARS-CoV-2 (COVID19) genome from an isolate specimen with coded results
SARS-CoV + SARS-Cov-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay SARSCoronavirusPlusSARSCoV2AgPrThrPtRespOrdIARapid is a qualitative test for the detection of SARS-Cov or SARS-CoV-2 (COVID19) antigens via rapdi immunoassay in respiratory specimens.
SARS-like coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection SARSLikecoronavirusNGenePrThrPtXXXOrdPrbAmpTarLabObs is a test for the SARS-like coronavirus N gene in non-respiratory specimens and via the probe target amplification method. LOINC code 94310-0.
SARS-like coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection SARSLikecoronavirusNGeneThreshNumPtXXXQnPrbAmpTarLabObs is a quantitative test for the SARS-like coronavirus N gene via the probe target amplification method and a threshold for detection in non-respiratory specimens. LOINC code 94313-4.
SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection SARSRelatedCoronavirusRNAPrThrPtRespOrdPrbAmpTar is a test for the SARS coronavirus related RNA (gene not specified). LOINC code 94502-2.
SARS-CoV-2 (COVID19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay SARScoronavirus2AbIgAACncPtSerPlasQnIALabObs is a quantitative test for the SARS-CoV-2 (COVID19) IgA antibody, arbitrary concentration, via immunoassay.
SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum or Plasma by Immunoassay SARScoronavirus2AbIgAPrThrPtSerPlasOrdIALabObs is a qualitative test for the SARS-CoV-2 (COVID19) IgA antibody in serum or plasma via immunoassay.
SARS-CoV-2 (COVID19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay SARScoronavirus2AbIgGAcncPtSerPlasQnIALabObs is a quantitative test for the SARS-CoV-2 (COVID19) IgG antibody via immunoassay. LOINC code 94505-5.
SARS-CoV-2 (COVID19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay SARScoronavirus2AbIgGPlusIgMPrThrPtSerPlasOrdIALabObs is a test for the SARS-CoV-2 (COVID19) IgG and IgM antibodies via immunoassay. It does not differentiate which is detected. LOINC code 94547-7.
SARS-CoV-2 (COVID19) IgG Ab [Presence] in Serum or Plasma by Immunoassay SARScoronavirus2AbIgGPrThrPtSerPlasOrdIALabObs is a qualitative test for the SARS-CoV-2 (COVID19) IgG antibody via immunoassay.
SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma Qualitative by Rapid immunoassay SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma Qualitative by Rapid immunoassay
SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma by Immunoassay SARScoronavirus2AbIgGandIgMpanelPtSerPlasQnIALabObs is a collection of quantitative tests for SARS-CoV-2 (COVID19) antibodies, IgG and IgM. LOINC code 94504-8.
SARS-CoV-2 (COVID19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay SARScoronavirus2AbIgMAcncPtSerPlasQnIALabObs is a quantitative test for the SARS-CoV-2 (COVID19) IgM antibody via immunoassay. LOINC code 94506-3.
SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Immunoassay SARScoronavirus2AbIgMPrThrPtSerPlasOrdIALabObs is a test for the SARS-CoV-2 (COVID19) IgM antibody in serum or plasma via immunoassay.
SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Rapid immunoassay SARScoronavirus2AbIgMPrThrPtSerPlasOrdIArapidLabObs is a test for the SARS coronavisus 2 IgM antibody via rapid immunoassay. LOINC code 94508-9.
SARS-CoV-2 (COVID19) Ab [Interpretation] in Serum or Plasma SARScoronavirus2AbImpPtSerPlasNomLabObs is an impression or interpretation of a specified SARS-CoV-2 (COVID19) lab test. Values are Positive or Negative.
SARS-CoV-2 (COVID19) E gene [Presence] in Unspecified specimen by NAA with probe detection SARScoronavirus2EGenePrThrPtXXXOrdPrbAmpTarLabObs is a test for the SARS-CoV-2 (COVID19) E gene on non-respiratory specimens via the probe target amplification method in non-respiratory specimens. LOINC code 94315-9.
SARS-CoV-2 (COVID19) E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection SARScoronavirus2EGeneThreshNumPtXXXQnPrbAmpTarLabObs is a quantitative test for the SARS-CoV-2 (COVID19) E gene via probe target ampification and with a threshold for detection in non-respiratory specimens. LOINC code 94509-7.
SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by NAA with probe detection SARScoronavirus2NGenePrThrPtRespOrdPrbAmpTar is the qualitative lab test for the detection of the SARS-CoV-2 (COVID19) N gene. LOINC code 94533-7.
SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by NAA with probe detection SARScoronavirus2NgenePrThrPtXXXOrdPrbAmpTar is a test for the SARS-CoV-2 (COVID19) RNA in non-respiratory specimens. LOINC code 94316-7.
SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection SARScoronavirus2NgeneThreshNumPtXXXQnPrbAmpTarLabObs is a quantitative test for the SARS-CoV-2 (COVID19) RNA via probe target amplification and a requirement for a certain threshold for detection. LOINC code 94510-5.
SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection SARScoronavirus2ORF1AbRegionThreshNumPtXXXQnPrbAmpTarLabObs is a quantitative test for the SARS-CoV-2 (COVID19) ORF Ab region via the probe target ampificatio method and with a threshold for detection in non-respiratory specimens. LOINC code 94511-3
SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection
SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection SARScoronavirus2ORF1abregionThreshNumPtRespiratoryQnProbeamptarLabObs is a quantitative test for the SARS-CoV-2 (COVID19) ORFl antibody region in respiratory specimens via a number threshold, probe target amplification method.
SARS-CoV-2 (COVID19) RNA panel - Respiratory specimen by NAA with probe detection SARScoronavirus2RNAPanelPtRespPrbAmpTar is a collection of tests for the SARS-CoV-2 (COVID19) RNA. LOINC code 94531-1.
SARS-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with non-probe detection SARScoronavirus2RNAPrThrPtNphOrdNonprobeamptarLabObs is a test for SARS-CoV-2 (COVID19) RNA nucleaic acids in nasopharynx specimens via non-probe, target amplification method.
SARS-CoV-2 (COVID19) RNA [Presence] in Respiratory specimen by NAA with probe detection SARScoronavirus2RNAPrThrPtRespOrdPrbAmpTar is the laboratory model for the SARS-CoV-2 (COVID19) specific for RNA, respiratory specimens, method of probe, target amplification. LOINC code 94500-6.
SARS-CoV-2 (COVID19) RNA [Presence] in Serum or Plasma by NAA with probe detection SARScoronavirus2RNAPrThrPtSerPlasOrdProbeamptarLabObs is a test for SARS-CoV-2 (COVID19) RNA in serum or plasma via a presence threshold, probe target amplification method.
SARS-CoV-2 (COVID19) RNA [Presence] in Unspecified specimen by NAA with probe detection SARScoronavirus2RNAPrThrXXXOrdPrbAmpTar is the laboratory model for the SARS-CoV-2 (COVID19) specific for RNA and method of probe, target amplification but not specific to specimen type. LOINC code 94309-2.
SARS-CoV-2 (COVID19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection SARScoronavirus2RdRpGenePrThePtRespOrdPrbAmpTar is a test for the SARS-CoV-2 (COVID19) RdRp gene in respiratory specimens. LOINC code 94534-5.
SARS-CoV-2 (COVID19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection SARScoronavirus2RdRpGenePrThrPtXXXOrdPrbAmpTarLabObs is a test for the SARS-CoV-2 (COVID19) RdRp gene via the probe target amplification method in non-respiratory specimens. LOINC code 94314-2.
SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection SARScoronavirus2RdRpgeneThreshNumPtRespiratoryQnProbeamptarLabObs is a quantitative test for the SARS-CoV-2 (COVID19) RdRp gene in respiratory specimens via a number threshold, probe target amplification method.
SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection SARScoronavirus2RdRpgeneThreshNumPtXXXQnProbeamptarLabObs is a quantitative test for the SASRS-CoV-2 (COVID19) RdRp gene in unspecified specimens via a number threshold, probe target amplification method.
SARS-CoV-2 (COVID19) S gene [Presence] in Respiratory specimen by NAA with probe detection SARScoronavirus2SgenePrThrPtRespiratoryOrdProbeamptarLabObs is a test for the SARS-CoV-2 (COVID19) S Gene in respiratory specimen via probe target amplification method.
SARS-CoV-2 (COVID19) S gene [Presence] in Unspecified specimen by NAA with probe detection SARScoronavirus2SgenePrThrPtXXXOrdProbeamptarLabObs is a test for the SARS-CoV-2 (COVID19) S Gene in unspecified specimen via probe target amplification method.
SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection SARScoronavirus2SgeneThreshNumPtRespiratoryQnProbeamptarLabObs is a quantitative test for the SARS-CoV-2 (COVID19) S gene in respiratory specimen, via a threshold number, probe target amplification method.
SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection SARScoronavirus2SgeneThreshNumPtXXXQnProbeamptarLabObs is a quantitative test for the SARS-CoV-2 (COVID19) S gene in unspecified specimens via a threshold number, probe target amplification method.
SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection SARSrelatedcoronavirusPlusMERScoronavirusRNAPrThrPtRespOrdPrbAmpTar is a combined test for SARS related coronavirus RNA (not gene specific) and MERS coronavirus RNA. LOINC code 94532-9.
SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection SARSrelatedcoronavirusRNAPrThrPtXXXOrdProbeamptarLabObs is a test for the SARS related coronavirus RNA in unspecified specimens via probe target amplification method.
Tobacco smoking status Smoking Status describes an individual's current state of tobacco use.
Travel History The country or countries to which the subject may have traveled.

Structures: Extension Definitions

These define constraints on FHIR data types that need to be complied with by conformant implementations

Certainty of Absence An extension to capture the degree certainty of the non-existence of a condition.
Certainty of Presence An extension to capture the degree certainty of the existence of a condition.
Reporting Priority The urgency level for which an observation must be reported.

Terminology: Value Sets

These define sets of codes used by systems conforming with this implementation guide

COVID-19 cardiovascular underlying condition reference set A set of codes that describe underlying cardiovascular medical conditions for COVID19.
COVID-19 Disease Severity Value Set The set of codes that describe the seriousness of the subject's COVID19 disease.
COVID-19 ICD 10 Diagnosis Value Set A set of ICD 10 codes that describe the diagnosed condition that is due to SARS coronavirus 2 infection.
COVID-19 SNOMED CT Diagnosis Value Set A set of SNOMED CT codes that describe the diagnosed condition that is due to SARS coronavirus 2 infection.
COVID-19 Signs and Symptoms Severity Value Set An assertion of the degree of severity of a sign or symptom as reported by the subject.
COVID-19 Signs and Symptoms Value Set The set of SNOMED CT codes that represent the signs and symptoms associated with COVID 19.
COVID-19 uncategorized underlying condition reference set A set of codes that describe conditions that are not otherwise categorized that are underlyers to COVID19.
COVID-19 gastrointestinal or hepatic underlying condition reference set A set of codes that describe underlying gastrointestinal or hepatic conditions for COVID19.
COVID-19 hemoglobinopathy underlying condition reference set A set of codes that describe underlying hemoglobinopathy conditions for COVID19
COVID-19 immune underlying condition reference set A set of codes that describe underlying immune conditions for COVID19
COVID-19 immunocompromised underlying condition reference set A set of codes that describe underlying immmunocompromised conditions for COVID19.
COVID-19 Underlying Medical Condition Value Set A set of SNOMED CT terms that descibe conditions that are present along with the COVID19 disease.
COVID-19 metabolic underlying condition reference set A set of codes that describe underlying metabolic conditions for COVID19
COVID-19 neurologic underlying condition reference set A set of codes that describe underlying conditions of a neurologic nature for COVID19.
COVID-19 renal underlying condition reference set A set of codes that describe underlying renal conditions for COVID19
COVID-19 respiratory underlying condition reference set A set of codes that describe underling respiratory conditions for COVID19.
Certainty of Absence Value Set The set of SNOMED CT codes that represent the leve of certainty that a condition does not exist.
Certainty of Presence Value Set The set of SNOMED CT codes that represent the level of certainty that a condition exists.
Close Contact Setting Value Set The SNOMED CT codes that describe teh situation in which a close contact exposure was made with an infected individual.
Country Codes Value Set The set of SNOMED CT codes that represent countries.
Detected-Not Detected-Inconclusive Value Set A set of SNOMED codes representing the result of a test as detected, not detected, equivalent, or inconclusive.
Healthcare Occupation Value Set A set of SNOMED CT codes that represent occupations within the health care industry.
Known Exposure LOINC Answer Value Set A set of LOINC answers for known expopsure
Positive/Negative Value Set A set of SNOMED codes representing the result of a test as positive or negative.
Pregnacy Status Value Set The set of codes that describe one's state of pregnancy.
Reporting Priorities Value Set A set of SNOMED codes representing how important it is to report a lab or other observation.
Smoking Status Value Set The set of SNOMED CT terms that describe the state of tobacco use.
State Codes Value Set The list of SNOMED CT codes that represent states.
Yes/No Value Set The SNOMED CT codes to answer in the affirmative or negative.